| A novel quinazolinone chalcone derivative induces mitochondrial dependent apoptosis and inhibits PI3K/Akt/mTOR signaling pathway in human colon cancer HCT-116 cells ZA Wani, SK Guru, AVS Rao, S Sharma, G Mahajan, A Behl, A Kumar, ... Food and Chemical Toxicology 87, 1-11, 2016 | 95 | 2016 |
| Biodegradable diblock copolymeric PEG-PCL nanoparticles: Synthesis, characterization and applications as anticancer drug delivery agents A Behl, VS Parmar, S Malhotra, AK Chhillar Polymer 207, 122901, 2020 | 71 | 2020 |
| Design and synthesis of antitumor heck-coupled Sclareol analogues: modulation of BH3 family members by SS-12 in autophagy and apoptotic cell death B Rah, SH Lone, RU Rasool, S Farooq, D Nayak, NA Chikan, ... Journal of Medicinal Chemistry 58 (8), 3432-3444, 2015 | 48 | 2015 |
| Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer AK Qazi, A Hussain, S Khan, MA Aga, A Behl, S Ali, SK Singh, SC Taneja, ... Cancer letters 359 (1), 47-56, 2015 | 36 | 2015 |
| Monoclonal antibodies in breast cancer: A critical appraisal A Behl, ZA Wani, NN Das, VS Parmar, C Len, S Malhotra, AK Chhillar Critical reviews in Oncology/hematology 183, 103915, 2023 | 34 | 2023 |
| Biodegradable PEG-PCL nanoparticles for co-delivery of MUC1 inhibitor and doxorubicin for the confinement of triple-negative breast cancer A Behl, S Solanki, SK Paswan, TK Datta, AK Saini, RV Saini, VS Parmar, ... Journal of Polymers and the Environment 31 (3), 999-1018, 2023 | 21 | 2023 |
| Anticancer activity of a novel quinazolinone-chalcone derivative through cell cycle arrest in pancreatic cancer cell line ZA Wani, AS Pathania, G Mahajan, A Behl, MJ Mintoo, SK Guru, ... J. Solid Tumors 5 (2), 73-85, 2015 | 21 | 2015 |
| Codelivery of gemcitabine and MUC1 inhibitor using PEG-PCL nanoparticles for breast cancer therapy A Behl, P Sarwalia, S Kumar, C Behera, MJ Mintoo, TK Datta, PN Gupta, ... Molecular Pharmaceutics 19 (7), 2429-2440, 2022 | 17 | 2022 |
| Nano-based drug delivery of anticancer chemotherapeutic drugs targeting breast cancer A Behl, AK Chhillar Recent patents on anti-cancer drug discovery 18 (3), 325-342, 2023 | 9 | 2023 |
| Lipid temperature relations of six thermophilous fungi B Singh, S Singh, A Behl Acta Botanica Indica, 1990 | 6 | 1990 |
| Chemotherapeutic strategies for combating Staphylococcus aureus infections N Sharma, AK Chhillar, S Dahiya, A Punia, P Choudhary, P Gulia, A Behl, ... Mini Reviews in Medicinal Chemistry 22 (1), 26-42, 2022 | 5 | 2022 |
| Detection and determination of the levels of physiologically active substances in non-alcoholic beverages A Behl, A Mishra, GP Sharma, V Mishra International Journal of Medical Toxicology & Legal Medicine 24 (3and4), 164-174, 2021 | 5 | 2021 |
| Rohitukine analogs as cyclin-dependent kinase inhibitors and a process for the preparation thereof RA Vishwakarma, SB Bharate, S Bhushan, DM Mondhe, SK Jain, ... US Patent 9,932,327, 2018 | 4 | 2018 |
| Phenological study of maidenhair tree Ginkgo biloba. S Yadav, AS Behl, SP Singh, JC Tewari Environment and ecology. Kalyani 3 (1), 121-122, 1985 | 3 | 1985 |
| Computational Design for Identification of Human Anti-MUC1 Heteroclitic Peptides in the Treatment of HER2-Positive Breast Cancer through Neural Network Training and Monomeric … A Behl, NN Das, KK Sharma, N Sharma, P Gulia, AK Chhillar Current Cancer Drug Targets 23 (3), 235-241, 2023 | | 2023 |
| Design and development of biodegradable polymeric nanoparticles for concomitant delivery of anti cancer agents A Behl Rohtak, 0 | | |
